KR870010865A - 피복된 복용 형태 - Google Patents

피복된 복용 형태 Download PDF

Info

Publication number
KR870010865A
KR870010865A KR870005022A KR870005022A KR870010865A KR 870010865 A KR870010865 A KR 870010865A KR 870005022 A KR870005022 A KR 870005022A KR 870005022 A KR870005022 A KR 870005022A KR 870010865 A KR870010865 A KR 870010865A
Authority
KR
South Korea
Prior art keywords
pill
composition
unit dose
dosage form
supply
Prior art date
Application number
KR870005022A
Other languages
English (en)
Inventor
게브레-셀라시에 이삭
고돈 로버트
멘취 마리안
유. 네스비트. 제이알 루셀
이. 트라폴드 마리
Original Assignee
원본미기재
워너-람버트 컴퍼니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 원본미기재, 워너-람버트 컴퍼니 filed Critical 원본미기재
Publication of KR870010865A publication Critical patent/KR870010865A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K1/00—Housing animals; Equipment therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

내용 없음

Description

피복된 복용 형태
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (14)

  1. (a) (메트) 아크릴 에스테르 및 디메틸 아미노에틸(메틸) 아크릴레이트의 잔사를 포함함는 양이온성공중합체를 포함하는 중합체 성분, 및
    (b) 중합체 성분을 가용화하기 위해서 효과적량의 최소 하나의 산으로 구성되는 피복 조성물.
  2. 제 1항에 있어서, (b)가 무기산 및 유기산으로 구성된 그룹으로부터 선택된 조성물.
  3. 제 2항에 있어서, (c) 최소 하나의 공정 보조제 및 (d) 가소제 또는 중성중합체로 구성되는 조성물.
  4. 제 3항에 있어서, (c)가 활석, 카올린 및 마그네슘 트리실리케이트, 실리콘 디옥사이드 및 탄산칼슘으로 구성되는 그룹으로부터 선택된 최소 하나의 물질인 조성물.
  5. 제 1항의 조성물로 피복된 제약학적 복용 형태.
  6. 제 4항의 조성물로 피복된 제약학적 복용 형태.
  7. 제 1항 물질의 피복 조성물 내부에 최소 하나의 섭취가능한 물질을 포함하는 평균직경이 약 0.35mm 내지 1.00mm인 환약.
  8. 제 7항에 있어서, 섭취가능한 물질이 제약학적 물질인 환약.
  9. 제 8항에 있어서, 제약학적 물질이 아세타미노펜인 환약.
  10. 제 7항의 환약 공급을 포함하는 단위 복용 캡슐.
  11. 제 9항의 환약 공급을 포함하는 단위 복용 캡슐.
  12. 제 7항의 환약 공급을 포함하는 단위 복용 주머니.
  13. 제 9항의 환약 공급을 포함하는 단위 복용 주머니.
  14. 제 7항의 환약 공급을 포함하는 다수복용 포장물.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR870005022A 1986-05-30 1987-05-21 피복된 복용 형태 KR870010865A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/869,504 US4786508A (en) 1986-05-30 1986-05-30 Coated dosage forms
US869504 1986-05-30

Publications (1)

Publication Number Publication Date
KR870010865A true KR870010865A (ko) 1987-12-18

Family

ID=25353663

Family Applications (1)

Application Number Title Priority Date Filing Date
KR870005022A KR870010865A (ko) 1986-05-30 1987-05-21 피복된 복용 형태

Country Status (12)

Country Link
US (1) US4786508A (ko)
EP (1) EP0247634A3 (ko)
JP (1) JPS62289528A (ko)
KR (1) KR870010865A (ko)
AU (2) AU7336587A (ko)
DK (1) DK275187A (ko)
FI (1) FI872364A (ko)
NO (1) NO872261L (ko)
NZ (1) NZ220411A (ko)
PH (1) PH24735A (ko)
PT (1) PT84963B (ko)
ZA (1) ZA872850B (ko)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4971791A (en) * 1985-08-26 1990-11-20 The Procter & Gamble Company Taste masking compositions
US4764375A (en) * 1985-09-11 1988-08-16 Kv Pharmaceutical Company Sachet drug delivery system
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
FR2630913A1 (fr) * 1988-05-09 1989-11-10 Delalande Sa Comprimes de sel(s) hydrosoluble(s) de diltiazem a liberation programmee et leur procede de fabrication
DE3900811A1 (de) * 1989-01-13 1990-07-19 Kali Chemie Pharma Gmbh Neue arzneiform
US4973470A (en) * 1989-06-26 1990-11-27 Warner-Lambert Company Sustained release pharmaceutical compositions
NZ267002A (en) * 1993-06-04 1997-07-27 Warner Lambert Co Chewable cold/sinus relief preparation comprising antihistamine and decongestant in a carrier consisting of silicon dioxide
US8071128B2 (en) * 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
DE19648576C2 (de) * 1996-11-23 1999-08-12 Lohmann Therapie Syst Lts Lutschtablette zur modifizierten Freisetzung von Wirkstoffen im Gastrointestinaltrakt
GB9801363D0 (en) * 1998-01-22 1998-03-18 Danbiosyst Uk Novel dosage form
US7658938B2 (en) 1999-02-22 2010-02-09 Merrion Reasearch III Limited Solid oral dosage form containing an enhancer
HUP0303700A3 (en) 2000-07-17 2006-07-28 Astellas Pharma Inc Chuo Ku Pharmaceutical composition improved in peroral absorbability
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
US20040247649A1 (en) * 2002-02-11 2004-12-09 Edizone, Lc Medicine-containing orally soluble films
US20050100640A1 (en) * 2002-02-11 2005-05-12 Pearce Tony M. Microcapsule edibles
US20040247746A1 (en) * 2002-02-11 2004-12-09 Edizone, Lc Delivery units of thick orally soluble polymer
US20050003048A1 (en) * 2002-02-11 2005-01-06 Edizone, Lc Electrolyte-containing orally soluble films
US20030224090A1 (en) * 2002-02-11 2003-12-04 Edizone, Lc Snacks of orally soluble edible films
US20040247744A1 (en) * 2002-02-11 2004-12-09 Edizone, Lc Vitamin-containing orally soluble films
JP4549609B2 (ja) * 2002-04-11 2010-09-22 エスエス製薬株式会社 被覆固形催眠製剤
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
FR2850577B1 (fr) * 2003-02-03 2005-04-15 Ethypharm Sa Particules enrobees a gout masque, leur procede de preparation et comprimes orodispersibles contenant lesdites particules
US20060147528A1 (en) * 2003-02-28 2006-07-06 Deepak Murpani Extended release, multiple unit dosage forms of phenytoin sodium and processes for their preparation
EP1694303A1 (en) * 2003-12-15 2006-08-30 Council Of Scientific And Industrial Research Taste masked pharmaceutical composition comprising ph sensitive polymer
US20050136114A1 (en) * 2003-12-19 2005-06-23 Council Of Scientific And Industrial Research Taste masked pharmaceutical compositions comprising bitter drug and pH sensitive polymer
US7294347B2 (en) * 2004-06-21 2007-11-13 Council Of Scientific And Industrial Research Coating compositions for bitterness inhibition
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
CA2584957C (en) 2004-10-21 2015-08-25 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US20060105038A1 (en) * 2004-11-12 2006-05-18 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions prepared by coacervation
US7378109B2 (en) * 2004-12-23 2008-05-27 Council Of Scientific And Industrial Research Pharmaceutical composition for improving palatability of drugs and process for preparation thereof
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
US7704977B2 (en) * 2006-04-07 2010-04-27 Merrion Research Iii Limited Solid oral dosage form containing an enhancer
US20070238942A1 (en) * 2006-04-10 2007-10-11 Esophamet Corp. Apparatus and method for detecting gastroesophageal reflux disease (gerd)
WO2009137078A1 (en) * 2008-05-07 2009-11-12 Merrion Research Iii Limited Compositions of peptides and processes of preparation thereof
AU2009202778B2 (en) * 2008-07-11 2014-05-08 Commonwealth Of Australia As Represented By And Acting Through The Department Of The Environment, Water, Heritage And The Arts Improved baiting method and composition
SG10201407965XA (en) 2009-12-02 2015-02-27 Aptalis Pharma Ltd Fexofenadine microcapsules and compositions containing them
US9089484B2 (en) 2010-03-26 2015-07-28 Merrion Research Iii Limited Pharmaceutical compositions of selective factor Xa inhibitors for oral administration
CN107073104A (zh) * 2014-08-04 2017-08-18 Dbv技术公司 食物过敏原组合物
JP7211704B2 (ja) 2015-01-29 2023-01-24 ノヴォ ノルディスク アー／エス Ｇｌｐ－１アゴニスト及び腸溶コーティングを含む錠剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5840529B2 (ja) * 1975-09-29 1983-09-06 明治製菓株式会社 ケイコウヨウセイザイノセイホウ
DE3106449A1 (de) * 1981-02-20 1982-09-09 Röhm GmbH, 6100 Darmstadt "in magensaft loesliche oder quellbare ueberzugsmasse und ihre verwendung in einem verfahren zum ueberziehen von arzneiformen"
DE3208791A1 (de) * 1982-03-11 1983-09-22 Röhm GmbH, 6100 Darmstadt Verfahren zum ueberziehen von arzneiformen mittes eines in wasser dispergierten ueberzugsmittels
JPS59110628A (ja) * 1982-12-17 1984-06-26 Sumitomo Chem Co Ltd 胃溶性被覆薬剤の製造方法
DE3581428D1 (de) * 1984-06-13 1991-02-28 Roehm Gmbh Verfahren zum ueberziehen von arzneiformen.

Also Published As

Publication number Publication date
NZ220411A (en) 1990-02-26
EP0247634A3 (en) 1988-03-02
US4786508A (en) 1988-11-22
NO872261D0 (no) 1987-05-29
DK275187D0 (da) 1987-05-29
AU7386391A (en) 1991-06-20
DK275187A (da) 1987-12-01
NO872261L (no) 1987-12-01
EP0247634A2 (en) 1987-12-02
PT84963B (pt) 1990-02-08
FI872364A (fi) 1987-12-01
PH24735A (en) 1990-10-01
PT84963A (en) 1987-06-01
FI872364A0 (fi) 1987-05-27
JPS62289528A (ja) 1987-12-16
ZA872850B (en) 1987-11-25
AU7336587A (en) 1987-12-03

Similar Documents

Publication Publication Date Title
KR870010865A (ko) 피복된 복용 형태
ES2062417T3 (es) Composiciones farmaceuticas de cimetidina.
NO975218D0 (no) Behandling av inflammatorisk tarmsykdom ved bruk av orale doseringsformer av omega-3-polyumettede syrer
BR9609033A (pt) Sistema de liberação controlada de líquido de alta viscosidade.
CA2019410A1 (en) Liquid polymer composition, and method of use
BRPI9509286B8 (pt) microcápsulas medicamentosas e/ou nutricionais para administração per si.
KR920703030A (ko) 방출 지연 조성물
ES2027005T3 (es) Procedimiento para preparar una formulacion farmaceutica de liberacion controlada de acrivastina.
PT93168A (pt) Processo para a preparacao de dispositivos distribuidores nomeadamente de capsulas contendo ingredientes activos
KR960021032A (ko) 연성 젤라틴 약제학적 용량형
ATE29836T1 (de) Verfahren zur herstellung einer pharmazeutischen zubereitung in form eines polyacrylat-films.
KR910018019A (ko) 니트로글리세린의 경피 투여형 약제
ATE399001T1 (de) Sphäroide, deren herstellungsverfahren und sphäroidenhaltige arzneimittel
DE69416034T2 (de) Pharmazeutische Zubereitung zur rektalen Verabreichung von pharmakologisch wirksamen Verbindungen
KR880012518A (ko) 나프탈-아세트산 유도체를 함유하는 진통 및 소염제약 조성물
KR910019608A (ko) 미감 차폐 및 서방성 약제용 피복물
KR890011595A (ko) 서맥 및 서부정맥 치료제
KR880007066A (ko) 우라피딜의 약제 형태
KR900013959A (ko) γ-카르블린 또는 그들의 제약학적으로 허용 가능한 산부가염 및/또는 수화물, 및 그들로 구성되는 제약학적 조성물
RU95104059A (ru) Лекарственная композиция с противоязвенным эффектом
KR890700580A (ko) 진경 작용을 갖는 제약 조성물
TH16465A (th) สูตรผสมสารเริ่มต้นสารฟอกจางเพอร์ออกซิแอซิคทีเคลือบไว้
GR1001558B (el) Φαρμακευτικό σκεύασμα με βάση υδροχλωρική βουφλομεδίλη υπο μορφήν δισκίων ελεγχομένης απελευ?ερώσεως & σχετική μέ?οδος παρασκευής.
KR830000048A (ko) 서방출형 제제의 제조방법
KR880002520A (ko) 망막증의 치료방법

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid